Patents by Inventor Karin Bernadet Fainberg

Karin Bernadet Fainberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small organic molecules for use in the treatment of neuroinflammatory disorders
    Patent number: 11779565
    Abstract: This invention provides small organic molecules useful as therapeutics of neurodegenerative diseases. Small organic molecules that act as inhibitors of bone morphogenetic proteins (BMPs) are useful in the treatment of neuroinflammatory disorders, in particular multiple sclerosis.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: October 10, 2023
    Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER
    Inventors: Arnon Karni, Karin Bernadet Fainberg
  • SMALL ORGANIC MOLECULES FOR USE IN THE TREATMENT OF NEUROINFLAMMATORY DISORDERS
    Publication number: 20210393582
    Abstract: This invention provides small organic molecules useful as therapeutics of neurodegenerative diseases. Small organic molecules that act as inhibitors of bone morphogenetic proteins (BMPs) are useful in the treatment of neuroinflammatory disorders, in particular multiple sclerosis.
    Type: Application
    Filed: July 22, 2021
    Publication date: December 23, 2021
    Applicant: THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER
    Inventors: Arnon KARNI, Karin Bernadet FAINBERG
  • Small organic molecules for use in the treatment of neuroinflammatory disorders
    Patent number: 11103479
    Abstract: This invention provides small organic molecules useful as therapeutics of neurodegenerative diseases. Small organic molecules that act as inhibitors of bone morphogenetic proteins (BMPs) are useful in the treatment of neuroinflammatory disorders, in particular multiple sclerosis.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: August 31, 2021
    Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER
    Inventors: Arnon Karni, Karin Bernadet Fainberg
  • Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases
    Patent number: 9663569
    Abstract: The invention provides pharmaceutical compositions for the treatment of neuroinflammatory or neurodegenerative diseases comprising a single or a combination of several blocking agent(s) of Bone Morphogenic Protein (BMP) signaling. The invention further provides methods of treatment of neuroinflammatory or neurodegenerative diseases comprising administering to a patient in need thereof the pharmaceutical compositions of the invention.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: May 30, 2017
    Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE, AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER
    Inventors: Arnon Karni, Yifat Amir Levi, Nataly Urshanski, Karin Bernadet Fainberg
  • USE OF BLOCKING AGENTS OF BONE MORPHOGENIC PROTEIN (BMP) SIGNALLING FOR THE TREATMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES
    Publication number: 20150139983
    Abstract: The invention provides pharmaceutical compositions for the treatment of neuroinflammatory or neurodegenerative diseases comprising a single or a combination of several blocking agent(s) of Bone Morphogenic Protein (BMP) signaling. The invention further provides methods of treatment of neuroinflammatory or neurodegenerative diseases comprising administering to a patient in need thereof the pharmaceutical compositions of the invention.
    Type: Application
    Filed: June 12, 2013
    Publication date: May 21, 2015
    Inventors: Arnon Karni, Yifat Amir Levi, Nataly Urshanski, Karin Bernadet Fainberg